Providing Unique Support for Health (PUSH) Study
Identifying and Engaging Urban HIV Infected and Uninfected YBMSM in Care
1 other identifier
interventional
631
1 country
1
Brief Summary
Project Narrative This 5-city proposal seeks to address HIV disparities among young (ages 15-24) Black and/or Latinx men who have sex with men (YBLMSM) and transgender women (YBLTW) in a multilevel intervention to identify, engage and retain, high-risk HIV-uninfected and HIV-infected urban YBMSM/TW in the HIV prevention and treatment cascade. The mobile-enhanced engagement intervention (MEI) is driven by the expressed and self-determined needs of each HIV infected and uninfected participant and includes care navigation, engagement, treatment and adherence. MEI also includes a supplemental Screening, Brief Intervention, and Referral for Treatment (SBIRT), to support YBLMSM/TW who face barriers accessing substance use treatment. By building upon existing case management services and flexibility to be adapted across ages and maturity and for prevention services, this intervention has the ability to transform networks, HIV and prevention care in YBLMSM/TW in cities with very high primary and secondary HIV transmission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 19, 2017
CompletedFirst Posted
Study publicly available on registry
June 21, 2017
CompletedStudy Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 6, 2022
CompletedMarch 31, 2023
March 1, 2023
3.8 years
June 19, 2017
March 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HIV Viral Suppression
Durable viral suppression (VL \< 20 copies/ml)
18-months
PrEP Uptake
Engagement in HIV pre-exposure prophylaxis (PrEP) services
18-months
Secondary Outcomes (1)
Engagement in substance abuse treatment services
6-months
Study Arms (2)
Mobile-enhanced Engagement Intervention
EXPERIMENTALMobile-enhanced engagement intervention (MEI) to support HIV-positive and high risk HIV-negative participants achieve sustained engagement and sustained retention in HIV treatment or HIV prevention (PrEP) and substance use services at 18-months.
Control - SOC Case Management
NO INTERVENTIONStandard of care (SOC) case management.
Interventions
Mobile phone based enhanced case management intervention for HIV positive \& HIV negative young Black men who have sex with men.
Eligibility Criteria
You may qualify if:
- Assigned male at birth
- years old
- English speaking
- Black/African American
- Hispanic/Latino ethnicity
- HIV positive, viral load of 20 or greater
- HIV negative, at high risk of HIV acquisition
- Sex with another male within last 12-months
- No plans to move outside of the research catchment area in next 18-months
- Able and willing to provide informed consent
- Not currently taking pre-exposure prophylaxis (PrEP)
- Not currently enrolled or planning to enrolled in an HIV vaccine trial
- Not currently enrolled or planning to enroll in an HIV adherence intervention
You may not qualify if:
- Birth-identified female
- under age 15
- Over age 24
- Non-English speaking
- No sex with another male in prior 12-months
- Not Black/African American or Hispanic identified
- HIV-positive, virally suppressed
- HIV-negative, not at high risk of HIV acquisition
- Unable or unwilling to provide consent for study participation
- Unable or unwilling to return for study visits
- Unwilling to provide an oral, blood or urine specimen for testing
- Currently taking pre-exposure prophylaxis (PrEP)
- Active or previous participation in an HIV vaccine trial
- Current participation in an adherence intervention (unless proof in the non-intervention arm)
- plan to relocate out of Baltimore, Washington DC, or Philadelphia in next 18- months
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Adolescent and Young Adult Health at Johns Hopkins Harriet Lane
Baltimore, Maryland, 21287, United States
Related Publications (4)
Arrington-Sanders R, Galai N, Falade-Nwulia O, Hammond C, Wirtz A, Beyrer C, Arteaga A, Celentano D. Patterns of Polysubstance Use in Young Black and Latinx Sexual Minority Men and Transgender Women and Its Association with Sexual Partnership Factors: The PUSH Study. Subst Use Misuse. 2024;59(3):317-328. doi: 10.1080/10826084.2023.2267655. Epub 2024 Jan 25.
PMID: 38146133DERIVEDShorrock F, Alvarenga A, Hailey-Fair K, Vickroy W, Cos T, Kwait J, Trexler C, Wirtz AL, Galai N, Beyrer C, Celentano D, Arrington-Sanders R. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women. AIDS Patient Care STDS. 2022 May;36(5):194-203. doi: 10.1089/apc.2021.0222.
PMID: 35507322DERIVEDArrington-Sanders R, Alvarenga A, Galai N, Arscott J, Wirtz A, Carr R, Lopez A, Beyrer C, Nessen R, Celentano D. Social Determinants of Transactional Sex in a Sample of Young Black and Latinx Sexual Minority Cisgender Men and Transgender Women. J Adolesc Health. 2022 Feb;70(2):275-281. doi: 10.1016/j.jadohealth.2021.08.002. Epub 2021 Sep 24.
PMID: 34580030DERIVEDArrington-Sanders R, Hailey-Fair K, Wirtz A, Cos T, Galai N, Brooks D, Castillo M, Dowshen N, Trexler C, D'Angelo LJ, Kwait J, Beyrer C, Morgan A, Celentano D; PUSH Study. Providing Unique Support for Health Study Among Young Black and Latinx Men Who Have Sex With Men and Young Black and Latinx Transgender Women Living in 3 Urban Cities in the United States: Protocol for a Coach-Based Mobile-Enhanced Randomized Control Trial. JMIR Res Protoc. 2020 Sep 16;9(9):e17269. doi: 10.2196/17269.
PMID: 32935662DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
David Celentano, ScD, MHS
Johns Hopkins Bloomberg School of Public Health
- PRINCIPAL INVESTIGATOR
Renata Sanders, MD, ScM, MPH
Johns Hopkins Bloomberg School of Public Health and JHU School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- Care providers and investigators will not know which patients are randomized to intervention or control.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2017
First Posted
June 21, 2017
Study Start
August 1, 2017
Primary Completion
May 28, 2021
Study Completion
September 6, 2022
Last Updated
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers.